A
Anna M. Cervantes-Arslanian
Researcher at Boston University
Publications - 66
Citations - 687
Anna M. Cervantes-Arslanian is an academic researcher from Boston University. The author has contributed to research in topics: Medicine & Stroke. The author has an hindex of 10, co-authored 47 publications receiving 338 citations. Previous affiliations of Anna M. Cervantes-Arslanian include Boston Medical Center & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
COVID-19 in patients with myasthenia gravis.
Pria Anand,Michaël C. C. Slama,Michaël C. C. Slama,Michelle Kaku,Charlene Ong,Anna M. Cervantes-Arslanian,Lan Zhou,William S. David,Amanda C. Guidon +8 more
TL;DR: This poster focuses on the development of a vaccine for coronavirus disease (COVID‐19) and its potential impact on patients with myasthenia gravis.
Journal ArticleDOI
Seizure as the presenting symptom of COVID-19: A retrospective case series.
Pria Anand,Abrar O. Al-Faraj,Elie Sader,Jonathan Dashkoff,Myriam Abdennadher,Rubachandran Murugesan,Anna M. Cervantes-Arslanian,Ali Daneshmand +7 more
TL;DR: In endemic areas with community spread of COVID-19, clinicians should be vigilant for the infection in patients who present with seizures, which may precede respiratory symptoms or prompt presentation to medical care.
Journal ArticleDOI
Cerebral Venous Sinus Thrombosis in COVID-19 Patients: A Multicenter Study and Review of Literature.
Mohamad Abdalkader,Shamsh P. Shaikh,James E. Siegler,Anna M. Cervantes-Arslanian,Cristina Tiu,Razvan Alexandru Radu,Vlad Eugen Tiu,Dinesh V Jillella,Ossama Mansour,Víctor Vera,Ángel Chamorro,Jordi Blasco,Antonio M. López,Mudassir Farooqui,Lauren Thau,Ainsley Smith,Santiago Ortega Gutierrez,Thanh N. Nguyen,Tudor G. Jovin +18 more
TL;DR: In this paper, the authors reviewed all published cases of CVST in patients with COVID-19 infection from January 1, 2020 to November 13, 2020 and evaluated their clinical presentations, risk factors, clinical management, and outcome.
Journal ArticleDOI
Posterior Reversible Encephalopathy Syndrome in Patients with Coronavirus Disease 2019: Two Cases and A Review of The Literature.
Pria Anand,K. H. Vincent Lau,David Y. Chung,Deepti Virmani,Anna M. Cervantes-Arslanian,Asim Mian,Courtney Takahashi +6 more
TL;DR: Risk factors for posterior reversible encephalopathy syndrome in patients with coronavirus disease 2019 may include underlying infection or immunomodulatory agents with endothelial effects in conjunction with modest blood pressure fluctuations.
Journal ArticleDOI
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults.
Shibani S. Mukerji,Vikas Misra,David R Lorenz,Anna M. Cervantes-Arslanian,Jennifer L. Lyons,Spyridon Chalkias,Alysse Wurcel,Deirdre Burke,Nagagopal Venna,Susan Morgello,Igor J. Koralnik,Dana Gabuzda +11 more
TL;DR: Characteristics frequently observed in CSF escape include HIV-1 infection >15 years, previous LLV, and M184V/I mutations inCSF, which provides a useful conceptual framework to identify causal factors and test therapeutics.